NeuroPace Inc. Files 8-K Report
Ticker: NPCE · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financials
TL;DR
NeuroPace filed an 8-K. Check for financial updates and other disclosures.
AI Summary
On March 27, 2025, NeuroPace Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD Disclosure and Other Events. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This 8-K filing indicates that NeuroPace Inc. is providing updated information to the SEC, which could include financial updates or disclosures of other material events relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Numbers
- 001-40337 — SEC File Number (Identifies the specific SEC filing for NeuroPace Inc.)
- 22-3550230 — IRS Employer Identification No. (Tax identification number for NeuroPace Inc.)
Key Players & Entities
- NeuroPace Inc. (company) — Registrant
- 455 N. Bernardo Avenue (location) — Principal executive offices address
- Mountain View, CA (location) — City and State of principal executive offices
- 94043 (location) — ZIP code of principal executive offices
- 6502372700 (phone_number) — Registrant's telephone number
FAQ
What specific events are disclosed under 'Other Events' in this 8-K filing?
The provided text does not specify the nature of the 'Other Events' beyond listing it as an item in the 8-K.
Are there any financial statements included with this filing?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item.
What is the primary business of NeuroPace Inc. based on the SIC code?
The Standard Industrial Classification (SIC) code 3841 indicates the company is in 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 27, 2025.
What is the principal executive office address for NeuroPace Inc.?
The principal executive offices are located at 455 N. Bernardo Avenue, Mountain View, CA 94043.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding NeuroPace Inc (NPCE).